Advanced Engineering Platform for OMV-Based Bacterial Vaccine...

added blog Health

2026-02-27 01:54:46 -

Advanced Engineering Platform for OMV-Based Bacterial Vaccine Development

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has today announced the launch of its comprehensive OMV-Based Bacterial Vaccines Development services. This new platform that integrates synthetic biology with advanced bacterial genome editing can address the historical limitations of traditional vaccine platforms, offering...

0 Comments 0 Shares 718 Views 0 Reviews